Skip to content

Dual-layer stent versus close cell-stents: a carotid angioplasty stenting randomized trial

Randomized double-blind clinical trial of carotid angioplasty with distal cerebral protection filter comparing closed-cell stent with double-layer stent

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-74srwz
Enrollment
Unknown
Registered
2019-10-23
Start date
2016-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, not specified as hemorrhagic or ischemic

Interventions

Patients with carotid stenosis above 70% who had symptoms of stroke will be included, they will be drawn by the coil flipping system and divided into two arms for treatment with carotid angioplasty an
Device
E04.100.814.868.500

Sponsors

Hospital de Clínicas de Ribeirão Preto - Universidade de São Paulo
Lead Sponsor
Hospital da Cidade de Passo Fundo
Collaborator

Eligibility

Age
18 Years to 101 Years

Inclusion criteria

Inclusion criteria: Patient over 18 years of age; Life expectancy greater than 1 year; Internal carotid artery stenosis> or = 70% associated with ipsilateral symptoms such as TIA, stroke or retinal ischemia; Internal carotid artery stenosis> or = 70% asymptomatic

Exclusion criteria

Exclusion criteria: Contraindication for antiplatelet therapy; Contraindication for use of iodinated contrast media; Patients with stroke or TIA classified by A-S-C-O as C1 or O1, that is, they present mitral stenosis; prosthetic heart valve; AMI in the previous 4 weeks; mural thrombus in the left chambers; left ventricular aneurysm; documented history of chronic or transient AF or flutter with or without "spontaneous echo contrast"; thrombus in the left atrium; sinus node disease syndrome; dilated cardiomyopathy; FE 800,000; LES; criteria for SAAF; Fabry disease; sickle cell anemia; ruptured cerebral aneurysm, with or without demonstration of spasm in the cerebral infarct territory; homozygous for hyperhomocystinuria; acute arterial dissection.

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be: the occurrence of emboli (yes or no), which are easily detected in the MRI of the brain in the FLAIR and DWI sequence after carotid angioplasty, are considered as markers of ischemic events.;The primary outcome will be: the number of pistons (in numbers) and the size of the pistons (in millimeters). which are easily detected in the MRI of the brain in the FLAIR and DWI sequence after carotid angioplasty, are considered as markers of ischemic events.;The primary endpoint will be: the size of the emboli (in millisiters), which are easily detected in the MRI of the brain in the FLAIR and DWI sequence after carotid angioplasty, are considered as markers of ischemic events.

Secondary

MeasureTime frame
Secondary outcomes are: Stroke (Stroke). Neurological complications will be assessed by experienced stroke-certified vascular neurologists applying the Ramkin Modified and National Institute of Health Stroke Scale (NIHSS);The secondary outcomes are: Transient Ischemic Attack (TIA). Neurological complications will be assessed by experienced stroke-certified vascular neurologists applying the Ramkin Modified and National Institute of Health Stroke Scale (NIHSS)

Countries

Brazil

Contacts

Public ContactJosé Vanzin

Hospital da Cidade de Passo Fundo

jrvanzin@gmail.com+5554991551689

Outcome results

None listed

Source: REBEC (via WHO ICTRP)